The burden of depression in prostate cancer
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: We sought to analyze the prevalence and incremental burden of depression among elderly with prostate cancer. Methods: We adopted a retrospective cohort design using the Surveillance, Epidemiology and End Results‐Medicare linked database between 1995 and 2003. Patients with prostate cancer diagnosed between 1995 and 1998 were identified and followed retrospectively for 1 year pre‐diagnosis and up to 8 years post diagnosis. In this cohort of patients with prostate cancer, depression during treatment phase (1 year after diagnosis of prostate cancer) or in the follow‐up phase was identified using the International Classification of Diseases‐Ninth Revision depression‐related codes. Poisson, general linear (log‐link) and Cox regression models were used to determine the association between depression status during treatment and follow‐up phases and outcomes–health resource utilization, cost and mortality. Results: Of the 50,147 patients newly diagnosed with prostate cancer, 4285 (8.54%) had a diagnosis of depression. A diagnosis of depression during treatment phase was associated with higher odds of emergency room visits (odds ratio (OR) = 4.45, 95% CI = 4.13, 4.80), hospitalizations (OR = 3.22, CI = 3.08, 3.37), outpatient visits (OR = 1.71, CI = 1.67, 1.75) and excess risk of death over the course of the follow‐up interval (hazard ratio = 2.82, CI = 2.60, 3.06). Health care costs associated with depression remained elevated compared with costs for men without depression, over the course of the follow‐up. Conclusions: Depression during the treatment phase was associated with significant health resource utilization, costs and mortality among men with prostate cancer. These findings emphasize the need to effectively identify and treat depression in the setting of prostate cancer. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921 · cited 1×
“The Charlson co-morbidity index based on diagnostic information from the entire observation interval was used to measure medical comorbidity using inpatient and outpatient Medicare claims data [17,18].”
MethodUnützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Bruce, M. L., Ten Have, T. R., Reynolds III, C. F., Katz, I. I., Schulberg, H. C., Mulsant, B. H., Brown, G. K., McAvay, G. J., Pearson, J. L., & Alexopoulos, G. S. (2004) · JAMA · doi:10.1001/jama.291.9.1081 · Cited by 963 · cited 1×
“Despite the development of effective management strategies that reduce the burden of depression among older adults [50–52], many studies describing interventions directed at psychosocial issues associated with the diagnosis of prostate cancer have focused on providing information about the disease rather than specific…”
BackgroundIdentifying Persons with Diabetes Using Medicare Claims Data
Hebert, P. L., Geiss, L. S., Tierney, E. F., Engelgau, M. M., Yawn, B. P., & McBean, A. M. (1999) · American Journal of Medical Quality · doi:10.1177/106286069901400607 · Cited by 403 · cited 1×
“, MI [26], diabetes [27], osteoarthritis [28], Parkinson's disease [29], medical co-morbidity [30]) and for procedures (e.”
BackgroundLepore, S. J., Helgeson, V. S., Eton, D. T., & Schulz, R. (2003) · Health Psychology · doi:10.1037/0278-6133.22.5.443 · Cited by 274
Impact of Cancer on Health-Related Quality of Life of Older Americans
Reeve, B. B., Potosky, A. L., Smith, A. W., Han, P. K., Hays, R. D., Davis, W. W., Arora, N. K., Haffer, S. C., & Clauser, S. B. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp123 · Cited by 211
Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study
Pirl, W. F., Siegel, G. I., Goode, M. J., & Smith, M. R. (2002) · Psycho-Oncology · doi:10.1002/pon.592 · Cited by 149 · cited 3×
“, hormonal therapy that decreases testosterone levels [37,38]), a direct effect of disease (e.”
BackgroundInfluential
Cited by
American Cancer Society prostate cancer survivorship care guidelines
Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon‐Ching, J. B., Slovin, S. F., et al. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21234 · Cited by 398
Long-Term and Latent Side Effects of Specific Cancer Types
Gegechkori, N., Haines, L., & Lin, J. J. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.06.003 · Cited by 286
Nead, K. T., Sinha, S., Yang, D. D., & Nguyen, P. L. (2017) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.07.016 · Cited by 96
Canoui‐Poitrine, F., Reinald, N., Laurent, M., Guery, E., Caillet, P., David, J., Tournigand, C., Lagrange, J., Bastuji‐Garin, S., Lemogne, C., et al. (2016) · Psycho-Oncology · doi:10.1002/pon.3886 · Cited by 71
Smith, D. P., Calopedos, R., Bang, A., Yu, X. Q., Egger, S., Chambers, S., & O’Connell, D. L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198679 · Cited by 41
Trevino, K. M., Stern, A., & Prigerson, H. G. (2020) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.03.012 · Cited by 11
Metadata
- Authors
- Jayadevappa, R., Malkowicz, S. B., Chhatre, S., Johnson, J. C., & Gallo, J. J.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2011-08-12
- Volume
- 21
- Issue
- 12
- Pages
- 1338-1345
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W1905297666
- Cited by
- 136
- References
- 8
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.